Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bengtson

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Journal of Managed Care & Specialty Pharmacy|July 25, 2022
Burden of illness in progressive fibrosing interstitial lung diseaseDavid Singer, Lindsay G S Bengtson, Craig S Conoscenti, et al.
Vascular Medicine (London, England)|December 3, 2014
Development of administrative data algorithms to identify patients with critical limb ischemiaWobo Bekwelem, Lindsay G S Bengtson, Niki C Oldenburg, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 8, 2023
Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation HistorySanjay Sethi, Brendan Clark, Lindsay G S Bengtson, et al.
The American Journal of Medicine|April 23, 2020
Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial FibrillationJ'Neka S Claxton, Alanna M Chamberlain, Pamela L Lutsey, et al.
Stroke|December 25, 2018
CHA<sub>2</sub>DS<sub>2</sub>-VASc Score and Stroke Prediction in Atrial Fibrillation in Whites, Blacks, and HispanicsLin Y Chen, Faye L Norby, Alanna M Chamberlain, et al.
Heart (British Cardiac Society)|December 13, 2017
Oral anticoagulants and liver injury: the threat of uncontrolled confoundingAlvaro Alonso, Richard F MacLehose, Lin Yee Chen, et al.
Journal of Managed Care & Specialty Pharmacy|May 3, 2023
Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterolSanjay Sethi, Swetha R Palli, Lindsay G S Bengtson, et al.
Circulation|August 24, 2016
Trajectories of Cardiovascular Risk Factors and Incidence of Atrial Fibrillation Over a 25-Year Follow-Up: The ARIC Study (Atherosclerosis Risk in Communities)Faye L Norby, Elsayed Z Soliman, Lin Y Chen, et al.
Journal of Managed Care & Specialty Pharmacy|October 31, 2017
Inhaled Corticosteroid-Containing Treatment Escalation and Outcomes for Patients with Asthma in a U.S. Health Care OrganizationLindsay G S Bengtson, Yanni Yu, Weijia Wang, et al.
Journal of the American Heart Association|April 15, 2018
Frequency of Care and Mortality Following an Incident Diagnosis of Peripheral Artery Disease in the Inpatient or Outpatient Setting: The ARIC (Atherosclerosis Risk in Communities) StudyCorey A Kalbaugh, Laura Loehr, Lisa Wruck, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Journal of Managed Care & Specialty Pharmacy|July 25, 2022
Burden of illness in progressive fibrosing interstitial lung diseaseDavid Singer, Lindsay G S Bengtson, Craig S Conoscenti, et al.
Vascular Medicine (London, England)|December 3, 2014
Development of administrative data algorithms to identify patients with critical limb ischemiaWobo Bekwelem, Lindsay G S Bengtson, Niki C Oldenburg, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 8, 2023
Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation HistorySanjay Sethi, Brendan Clark, Lindsay G S Bengtson, et al.
The American Journal of Medicine|April 23, 2020
Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial FibrillationJ'Neka S Claxton, Alanna M Chamberlain, Pamela L Lutsey, et al.
Stroke|December 25, 2018
CHA<sub>2</sub>DS<sub>2</sub>-VASc Score and Stroke Prediction in Atrial Fibrillation in Whites, Blacks, and HispanicsLin Y Chen, Faye L Norby, Alanna M Chamberlain, et al.
Heart (British Cardiac Society)|December 13, 2017
Oral anticoagulants and liver injury: the threat of uncontrolled confoundingAlvaro Alonso, Richard F MacLehose, Lin Yee Chen, et al.
Journal of Managed Care & Specialty Pharmacy|May 3, 2023
Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterolSanjay Sethi, Swetha R Palli, Lindsay G S Bengtson, et al.
Circulation|August 24, 2016
Trajectories of Cardiovascular Risk Factors and Incidence of Atrial Fibrillation Over a 25-Year Follow-Up: The ARIC Study (Atherosclerosis Risk in Communities)Faye L Norby, Elsayed Z Soliman, Lin Y Chen, et al.
Journal of Managed Care & Specialty Pharmacy|October 31, 2017
Inhaled Corticosteroid-Containing Treatment Escalation and Outcomes for Patients with Asthma in a U.S. Health Care OrganizationLindsay G S Bengtson, Yanni Yu, Weijia Wang, et al.
Journal of the American Heart Association|April 15, 2018
Frequency of Care and Mortality Following an Incident Diagnosis of Peripheral Artery Disease in the Inpatient or Outpatient Setting: The ARIC (Atherosclerosis Risk in Communities) StudyCorey A Kalbaugh, Laura Loehr, Lisa Wruck, et al.
Pageof 8